RVLPQ OTC
RVL Pharmaceuticals plc
1W: +900.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$38M
+30.9% ▲
Capital Expenditures
$752K
+57.8% ▲
5Y CAGR: -35.8%
Free Cash Flow
-$39M
+31.8% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$4M
+105.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$110M | -$271M | -$80M | -$65M | -$52M |
| Depreciation & Amort. | $82M | $57M | $21M | $8M | $375K |
| Stock-Based Comp. | $0 | $5M | $5M | $8M | $4M |
| Change in Working Capital | -$26M | -$16M | -$2M | -$7M | $4M |
| Other Non-Cash Items | $306M | $285M | $74M | $2M | $5M |
| Operating Cash Flow | $38M | $34M | $18M | -$55M | -$38M |
| — Investing Activities — | |||||
| Capital Expenditures | -$4M | -$4M | -$3M | -$2M | -$752K |
| Acquisitions (Net) | $10K | $17K | $50K | $90K | $878K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $118M | $0 |
| Investing Cash Flow | -$4M | -$4M | -$3M | $116M | $126K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$54M | -$2M | -$50M | -$167M | $18M |
| Stock Repurchased | $0 | -$3M | -$8M | $0 | $0 |
| Dividends Paid | -$2K | $0 | $0 | $0 | $0 |
| Other Financing | -$2K | $0 | -$749K | -$783K | $48K |
| Financing Cash Flow | $4M | -$5M | $4M | -$135M | $42M |
| Net Change in Cash | $36M | $25M | $18M | -$74M | $4M |
| Cash End of Period | $71M | $96M | $114M | $40M | $45M |
| Free Cash Flow | $33M | $30M | $14M | -$57M | -$39M |